Why Teva Pharmaceutical Is Rallying 10% Today
Following fourth-quarter financial results that outpaced industry watchers' estimates, shares in Teva Pharmaceutical (NYSE: TEVA) are up nearly 10% at noon on Wednesday.
Teva Pharmaceutical is in the midst of restructuring its business to reduce expenses and reinvigorate sales in the face of headwinds associated with generic competition to its top-selling multiple sclerosis drug, Copaxone. In Q4, it appears its turnaround may be taking hold.
Image source: Getty Images.
Source Fool.com


